1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | -7.28K | 31.71% |
| Net profit | -844.33K | 80.32% |
| EBITDA | -834.97K | 79.52% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.65M |
Number of shares | 1.81M |
52-week high/low | €3.91 - €0.11 |
| Dividends | No |
Beta | 1.07 |
P/E ratio | 0.36 |
PEG ratio | 0.00 |
P/B ratio | 1.11 |
P/S ratio | 0.00 |
Company profile
| Name | Protagenic Therapeutics Inc |
| CEO | Garo H. Armen |
| Employees | 2 |
Discover assets
Shareholders of Protagenic Therapeutics Inc also invest in the following assets
